chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt sat for 15 min, had some water, after 15 minutes pt reported feeling better. BP and HR was checked before discharge.
Around the 2nd or 3rd of February I started seeing double vision. I went to the eye doctor about a week or ago. The Dr. said it was muscle pulling of my eyes.  Tomorrow I have cataract surgery. One March 4th I have a follow up to discuss the double vision. If I cover one eye then I can see fine,  but when I look with both eyes I am still seeing double vision.
even if vaccinated, sequels affect, suspected vaccination failure; sequels, it, I had it,; Painful; pain makes you scream; itching on head, tendons, itching sores on back that spread; itching on eye; Anxiety; chills; Not able to sleep; tiredness; feeling insecure; Not feeling well yet; sores that itch horribly; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, screaming, pruritus, eye pruritus, anxiety, chills, insomnia, tiredness, feelings of worthlessness, feeling unwell and skin ulcer. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was resolved with sequelae and the outcome of the pain, screaming, pruritus, eye pruritus, anxiety, chills, insomnia, tiredness, feelings of worthlessness, feeling unwell and skin ulcer were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain, screaming, pruritus, eye pruritus, anxiety, chills, insomnia, tiredness, feelings of worthlessness, feeling unwell and skin ulcer to be related to Shingles vaccine.     Additional Information: GSK receipt date: 10-JAN-2023 Reporter's comment: This case was reported by a consumer via interactive digital media. The patient self-reported as had it, it was so painful, the pain made you scream and even if you were vaccinated, sequels affect your body. The patient still had itching in tendons, head, in one eye.  The patient said all of that gives you anxiety, chills, you did not sleep, tiredness, you feel insecure. The patient had sores that itch horribly at her back which had spread.  The patient said if someone knows a cure tell,  the patient was still not feeling ok, help please. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow up would not possible, as no contact details were available.
severe headache from day of injection lasting  approximately 72 hours; fatigue beginning from date of injection and lasting  approximately 48 hours; joint pain and feeling of inflammation in the spine from base of head to tailbone, back pain, leg pain along posterior chain, beginning  48 hours after injection and lasting 72 hours or more after start of pain.  Alleviated somewhat by 600 mg ibuprofen every 6 hours.
No known adverse effects; a patient received a dose of VARIVAX via the intramuscula route in error; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 10-MAY-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R013303, expiry date: 08-MAY-2020, intramuscularly (dose and anatomical location were not provided) for prophylaxis. The vaccine was administered via a intramuscular route in error. No adverse effects were reported.
Pt had wheezing, sneezing, & hives 15' p/taking MMR/OPV; lungs bilateral wheezing noted which cleaared by Proventil inhaler of Epi; referred to ER for eval;
Pt has a PMH of non-oxygen dependent COPD and physical debility and deconditioning with recent fall and subsequent hip fracture (status post hip surgery). She has had rhinorrhea, sinus congestion with a nonproductive cough for 2 weeks. She tested positive for both COVID and Influenza A.
After receiving the Yellow Fever vaccine 7-10 min later the patient started feeling heart palpitations, her heart rate was 142, after sitting down and drinking a glass of water her heart rate was 64, 15 min later her heart rate was 59.
For 2 Hours. Chills - Shivering, Shallow fast breathing.  For 12 Hours Sore stiff neck on left side (vaccination in left arm) Headache on back
Patient contacted me stating her heart felt like it was racing and she could feel it in her chest. I took her heart rate and blood pressure. Her heart rate was 96 the first reading and 106 the second. Her blood pressure was 168/100 the first reading and 182/102. I explained that her blood pressure was extremely high and she needed to go to the emergency room. I offered to call EMS, but she insisted she did not want that. She left my pharmacy and went immediately to the ER where she was treated to lower her BP and HR. Once they had that under control they discharged her with a prescription for metoprolol succ 25mg that she is only supposed to take if her BP goes above 160. I filled the medication and helped her buy a BP monitoring system. She was feeling much better now.
male patient received an expired dose of havrix; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 57-year-old male patient who received HAV (Havrix) (batch number K4Y4L, expiry date 17th June 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 20th June 2022, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 20th June 2022, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 21-Jun-2022 Reporters comment: The certified medical assistant reported that the patient received an expired dose of Havrix. The reporter consent for follow-up. Additional Supportive information: The patient received expired dose of Havrix vaccine, which led to expired vaccine used.
I am 16 weeks pregnant today and I received my first dose of moderna in March.; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (I am 16 weeks pregnant today and I received my first dose of moderna in March.) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (I am 16 weeks pregnant today and I received my first dose of moderna in March.). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (I am 16 weeks pregnant today and I received my first dose of moderna in March.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.    Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Internal review on 19-Jul-2021 resulted in updates to the pregnancy details.
Transverse Myelitis; This is a spontaneous report from a contactable physician. A 74-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for inhection), via an unspecified route of administration on 25Mar2021 (at the age of 74 years old) (Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, was the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Apr2021, the patient experienced transverse myelitis. The patient was given IV methylprednisolone sodium succinate (SOLU-MEDROL) as treatment. The patient was hospitalized for transverse myelitis for 3 days. The event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Since the vaccination, the patient been tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 01May2021. The outcome of the event was recovering at the time of report.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the available information and known product profile, the causal relationship between the reported transverse myelitis and the use of BNT162B2 cannot  be fully excluded. There is limited information in this case precluding a more meaningful assessment. The case will be assessed further upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Around 4 pm I had flu like symptoms. Headache, back pain, fatigue, chills, sweats.  Around 5:30 I started feeling light-headed. I got out of bed and fainted on the floor. Laid there for a few moments. Got water. Laid back into bed and my body completely locked up. It felt like there were pins and needles coursing through my entire body. I couldn?t bend or move my legs. My wrists were bent down and my fingers all locked together. I could not move them at all. I was screaming out in pain. It was the worst pain I?ve ever felt. My roommate called 911. Paramedics arrived and took my temperature and blood pressure. They tried calming me down. eventually I did. And my fingers and legs unlocked but I continued having a severe headache, back pain, muscle aches and nausea. I woke up every hour of the night and threw up several times.  It?s been 24 hours after the shot and I am still having headaches fatigue and muscle spasms.
positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (positive for Covid-19) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (positive for Covid-19). At the time of the report, COVID-19 (positive for Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, COVID-19: (Positive) Positive for Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
-Extreme shortness of breath, difficulty breathing.                                       -Extreme lightheadedness, weakness, and dizziness.                                       -Loss of vision and hearing.                                         -Low pulse rate: 54 after reaction compared to 75 during normal exam.
Patient presents to the ED with > 12 hours of vomiting the day after receiving Pfizer COVID-19 vaccine #2.  From the ED note:  14-year-old previously well here for vomiting.  Patient got her second Covid shot yesterday 230.  5:30 AM patient awakened with nausea and vomiting.  She has vomited all day long (not bloody or bilious).  Late afternoon they called primary care who called in prescription for Zofran.  She took 4 mg at 6 PM but continued to feel unwell and vomit so came for evaluation.  No fever.  Some intermittent abdominal discomfort but no significant pain.  No stool today.  Decreased urine output. No fever, chills, dysuria, headache.  No known ill contacts.  Benign chem (elevated bun c/w dehydration). after fluids pt reports feeling much better:significantly improved appearance: good color, smiling, sitting up and able to walk around comfortably. improved hr, remains with nontender abd. Pt took po's without difficulty/N/V and voided in ED. Currently no evidence of bacterial infection, surgical abd/obstruction, significant dehydration/metabolic derangement, CNS process.  May be related to vaccine vs possible viral vs food - although less likely given no known ill contact. Well appearing, taking po's well now. plan for discharge and outpatient f/u.
Patient was given a Lower than authorized dose of the correct formulation due to being mixed with dilutent.
Patient got tingling sensation on her palm - and felt numbness on index and thumb of Lt hand, lasted for about an hour before diminishing.
Within 5 minutes after patient received the flu shot pt had rashes on the right arm, bumps and it was itching and swollen, pt had also rashes on the neck within 10 min and started to feel weird.
I started getting small red marks on my skin about 3 days after the injection. They are about 8-10 in number now and are on my arms and chest area predominantly.  I was also feeling muscle soreness which is a bit better and I still feel very fatigued.
Was not able to take his last dose of Vivotif; Spontaneous report received on 16JAN2020.  Based on the information obtained from the nurse, two individual case safety reports PVX2020-120 (wife) and PVX2020-121 (husband) were created and cross-linked in the database.  In this case, a male consumer "was not able to take his last dose of Vivotif" (PT: Product dose omission). He was receiving Vivotif capsule for immunisation. On 15JAN2020, the consumer's wife took her fourth dose of Vivotif and then took her husband's fourth dose mistakenly right after her last dose. Thus, he was not able to take his last dose. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer was not able to take his last Vivotif dose (missed dose) as his wife mistakenly took his Vivotif dose. Considering the nature of the event, the causality of missed dose is assessed as not applicable to Vivotif.; Sender's Comments: A consumer was not able to take his last Vivotif dose (missed dose) as his wife mistakenly took his Vivotif dose. Considering the nature of the event, the causality of missed dose is assessed as not applicable to Vivotif.
9/20/10 Came to Health Unit 1 week after TDAP injection for consultation. Inj. site had approx. 2.5 cm and warm to touch. No inflammation. No other sympt. Afebrile T 96.8 BP 100/60. Took TYLENOL first 2 days after inj. Knot in arm inj. site sl. sore. Given 500mg TYLENOL x 1 - Warm pk every hour x 15 min.
Elevated heart rate?atrial Fibulation Cardio version-03/25/2021
very red at the injection site; warm at the injection site; bumpy at the injection site; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt tired), VACCINATION SITE ERYTHEMA (very red at the injection site), VACCINATION SITE WARMTH (warm at the injection site) and VACCINATION SITE MASS (bumpy at the injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 12-Mar-2021, the patient experienced FATIGUE (felt tired). On 20-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm at the injection site) and VACCINATION SITE MASS (bumpy at the injection site). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (very red at the injection site). At the time of the report, FATIGUE (felt tired), VACCINATION SITE ERYTHEMA (very red at the injection site), VACCINATION SITE WARMTH (warm at the injection site) and VACCINATION SITE MASS (bumpy at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant  medication included vitamins  Treatment included ice pack   Reporter did not allow further contact
Constant feeling of being stung by a bee. Arm where shot was administered is swollen.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2013, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 23-JAN-2014, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. The patient was prescribed famciclovir (FAMVIR), tramadol, and gabapentin for management of her painful symptoms and chronic pain. On or about 11-MAR-2014, the patient sought subsequent treatment from a physician, which was diagnosed as chronic post herpetic neuralgia. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Patient described tingling, stinging right after the vaccine was administered. Approx. 10 minutes later patient described numbness in the arm the vaccine was administer in.
Approx 5 cm in diameter erythema and approx. 7 cm swelling anterior left thigh. Treated with Cephalexin 125MG/5ML, 6 Milliliter every 12 hours x 10 days.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection arm soreness) and FATIGUE (General fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041A21A and 046A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included INSULIN LISPRO (HUMALOG), LISINOPRIL, LAMOTRIGINE, METFORMIN and ATORVASTATIN for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE PAIN (Injection arm soreness) and FATIGUE (General fatigue). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Injection arm soreness) and FATIGUE (General fatigue) outcome was unknown.
SWELLING AND MILD SORENESS AT INJECTION SITE, RASH (MAY HAVE BEEN REACTION TO BANDAGE APPLIES AFTER THE SHOT). REACTION WAS NOT SIGNIFICANT ENOUGH TO REQUIRE MEDICAL ATTENTION AND PASSED COMPLETELY IN 2 WEEKS. THE RASH LASTED LONGER THAN THE SWELLING.  DID NOT HAVE THIS WITH THE FIRST SHOT.  WITH BOTH DOES OF THE VACCINE MY OPPOSITE ARM SEEMS TO HAVE SYMPATHETIC PAIN AT INJECTION SITE.
Arm a little sore at injection spot.  On Feb 6, 2021,  being 9 days after first dose I  felt a lump with swelling on right side near neck. I applied  warm wash cloth several times a day and it has gone down, however nodule can still be felt today 2-13-2021..still have some swelling.  My next dose is scheduled for 2-18-2021.
Patient states they are vaccinated for COVID x2. Unknown manufacturer or dates of vaccines. Patient hospitalized with dyspnea and tested positive for COVID.
Vaccine was inadvertently administered to a minor - vaccine is not approved for less than 18 years of age. There were no symptoms of side effects from vaccination
heavy throat; burning tongue; tongue is red; headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (heavy throat), TONGUE DISCOMFORT (burning tongue), TONGUE ERYTHEMA (tongue is red) and HEADACHE (headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL DISCOMFORT (heavy throat), TONGUE DISCOMFORT (burning tongue), TONGUE ERYTHEMA (tongue is red) and HEADACHE (headache). At the time of the report, OROPHARYNGEAL DISCOMFORT (heavy throat), TONGUE DISCOMFORT (burning tongue), TONGUE ERYTHEMA (tongue is red) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Foggy memory; Her husband got sick; Arm soreness; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Foggy memory), ILLNESS (Her husband got sick), MYALGIA (Arm soreness) and FATIGUE (Tiredness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced CONFUSIONAL STATE (Foggy memory). In 2021, the patient experienced ILLNESS (Her husband got sick), MYALGIA (Arm soreness) and FATIGUE (Tiredness). At the time of the report, CONFUSIONAL STATE (Foggy memory), MYALGIA (Arm soreness) and FATIGUE (Tiredness) outcome was unknown and ILLNESS (Her husband got sick) had resolved.            Concomitant medications details are not provided by the Reporter. No treatment information is provided. Action taken with mRNA is not applicable.
Described as projective vomiting, pain in jaw, and dull ache in lower ear lobes, felt like her ear lobes had rocks hanging from them.
Non-stop high screaming and crying, Breathing at very fast pace, nervous type body tic about every 3-4 seconds, gasping for air, 101 fever (on infant tylenol). Called ER spoke to nurse and then Dr., told to stay home watch him and call or come in if symptoms got worse or if he turned blue or gray.
On June 30, 2021, I had an injury to my chest.  I developed chest pain, difficulty with breathing deeply, and shortness of breath.  On August 9, I still have all of those symptoms and the chest pain has worsened slightly.